174 related articles for article (PubMed ID: 30944668)
1. Secreted Frizzled-Related Protein 2 Is Associated with Disease Progression and Poor Prognosis in Breast Cancer.
Huang C; Ye Z; Wan J; Liang J; Liu M; Xu X; Li L
Dis Markers; 2019; 2019():6149381. PubMed ID: 30944668
[TBL] [Abstract][Full Text] [Related]
2. Value of Plasma Methylated SFRP2 in Prognosis of Gastric Cancer.
Yan H; Chen W; Ge K; Mao X; Li X; Liu W; Wu J
Dig Dis Sci; 2021 Nov; 66(11):3854-3861. PubMed ID: 33216241
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic value of the methylation status of secreted frizzled-related protein 2 in colorectal cancer.
Tang D; Liu J; Wang DR; Yu HF; Li YK; Zhang JQ
Clin Invest Med; 2011 Apr; 34(2):E88-95. PubMed ID: 21463549
[TBL] [Abstract][Full Text] [Related]
4. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
5. Secreted Frizzled-Related Protein 2 and Extracellular Volume Fraction in Patients with Heart Failure.
Yang S; Chen H; Tan K; Cai F; Du Y; Lv W; Hu Q; Hu Y; Huang Y
Oxid Med Cell Longev; 2020; 2020():2563508. PubMed ID: 32454934
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of serum MACC1 in breast cancer patients.
Tan W; Xie X; Li L; Tang H; Ye X; Chen L; Tang W; Gao J; Pan L; Zhang X; Ye F; Li X; Yang L; Xie X; Zheng W
Oncotarget; 2016 Dec; 7(51):84408-84415. PubMed ID: 27793048
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic potential of serum angiopoietin-2 expression in human breast cancer.
Li P; He Q; Luo C; Qian L
Int J Clin Exp Pathol; 2015; 8(1):660-4. PubMed ID: 25755760
[TBL] [Abstract][Full Text] [Related]
8. The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer.
Chi Y; Yao L; Hu X; Huang S; Huang N; Li S; Shao Z; Wu J
Oncotarget; 2016 Mar; 7(12):14951-62. PubMed ID: 26908452
[TBL] [Abstract][Full Text] [Related]
9. Serum Dickkopf-1 expression level positively correlates with a poor prognosis in breast cancer.
Zhou SJ; Zhuo SR; Yang XQ; Qin CX; Wang ZL
Diagn Pathol; 2014 Aug; 9():161. PubMed ID: 25116444
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients.
Huo J; Hu J; Liu G; Cui Y; Ju Y
Arch Gynecol Obstet; 2017 Feb; 295(2):459-465. PubMed ID: 27975129
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of sCIP2A levels in breast cancer.
Xing ML; Lu YF; Wang DF; Zou XY; Zhang SX; Yun Z
Eur Rev Med Pharmacol Sci; 2016; 20(1):82-91. PubMed ID: 26813457
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
[TBL] [Abstract][Full Text] [Related]
14. Performance of a MethyLight assay for methylated SFRP2 DNA detection in colorectal cancer tissue and serum.
Li H; Wang Z; Zhao G; Ma Y; Chen Y; Xue Q; Zheng M; Fei S
Int J Biol Markers; 2019 Mar; 34(1):54-59. PubMed ID: 30852954
[TBL] [Abstract][Full Text] [Related]
15. Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer.
Janni WJ; Rack B; Terstappen LW; Pierga JY; Taran FA; Fehm T; Hall C; de Groot MR; Bidard FC; Friedl TW; Fasching PA; Brucker SY; Pantel K; Lucci A
Clin Cancer Res; 2016 May; 22(10):2583-93. PubMed ID: 26733614
[TBL] [Abstract][Full Text] [Related]
16. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.
Liu W; Xu Y; Guan H; Meng H
Cancer Biomark; 2018; 22(3):487-493. PubMed ID: 29843213
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of secreted frizzled related protein 2 gene promoter serves as a noninvasive biomarker for HBV-associated hepatocellular carcinoma.
Xiang L; Chen LM; Zhai YJ; Sun WJ; Yang JR; Fan YC; Wang K
Life Sci; 2021 Apr; 270():119061. PubMed ID: 33454364
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.
Darlix A; Hirtz C; Thezenas S; Maceski A; Gabelle A; Lopez-Crapez E; De Forges H; Firmin N; Guiu S; Jacot W; Lehmann S
BMC Cancer; 2019 Jan; 19(1):110. PubMed ID: 30700265
[TBL] [Abstract][Full Text] [Related]
19. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
Wang SY; Li Y; Jiang YS; Li RZ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of serum tenascin-C levels in breast cancer.
Tastekin D; Tas F; Karabulut S; Duranyildiz D; Serilmez M; Guveli M; Vatansever S
Tumour Biol; 2014 Jul; 35(7):6619-25. PubMed ID: 24696262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
